Assistant Professor, the Interdisciplinary Cluster for applied Genoproteomics (GIGA) Research Center, Cancer Department, College of Biomedical Science, University of Liege, Liege, Belgium, since July 2007.
Postdoctoral fellow with Prof. Yves A. DeClerck, Division of Hematology-Oncology, Department of Pediatrics, Children’s Hospital Los Angeles, University of Southern California, Los Angeles. November 2002 – Jun 2007.
Postdoctoral fellow with Prof. Agnes Noel, Department of Tumor and Developmental Biology, University of Liège, Liege, Belgium. October 2001 – October 2002.
Ph. D student with Prof. Jean Michel Foidart, Department of Tumor and Developmental Biology, University of Liège, Liege, Belgium. September 1995 – September 2001.
Research Position with Prof. Jose Remacle, Department of Biochemistry and Cellular Biology, University of Namur, (Belgium). October 1992 – August 1995.
Bajou,K., Herkenne,S., Thijssen,V.L., D'Amico,S., N.guyen,N.Q.N., Bouché,A., Tabruyn,S., Srahna,M., Carabin,J.V., Nivelles,O., Paques,C., Cornelissen,I., Lion,M., Noel,A., Gils,A., Vinckier,S., Declerck,P.J., Griffioen,A.W., Dewerchin,M., Martial,J.A., Carmeliet,P. and Struman,I.
PAI-1 mediates the anti-angiogenic and pro- fibrinolytic effects of 16K prolactin.
Nat.Med., 2014 jul, 20, 741-747.
Bajou,K., Peng,W., Laug,W.E., Maillard,C., Noel,A., Foidart,J.M., Martial,J.A., DeClerck,Y.A.
Plasminogen activator inhibitor-1 protects endothelial cells from FasL-mediated apoptosis.
Cancer Cell, 2008, 14, 324-334
Bajou,K., Maillard,C., Jost,M., Lijnen,R.H., Gils,A., Declerck,P., Carmeliet,P., Foidart,J..M., Noel,A.
Host-derived plasminogen activator inhibitor-1 (PAI-1) concentration is critical for in vivo tumoral angiogenesis and growth.
Oncogene, 2004, 23, 6986-90.
Bajou,K., Masson,V., Gerard,R.D., Schmitt,P.M., Albert,V., Praus,M., Lund,L.R., Frandsen,T.L., Brunner,N., Dano,K., Fusenig,N.E., Weidle,U., Carmeliet,G., Loskutoff,D., Collen,D., Carmeliet,P., Foidart,J.M., Noel,A.
The Plasminogen Activator Inhibitor PAI-1 Controls In Vivo Tumor Vascularization by Interaction with Proteases, Not Vitronectin. Implications for antiangiogenic strategies.
J. Cell. Biol., 2001, 152, 777-784.
I.F. = 12.915.
Bajou,K., Noel,A., Gerard,R.D., Masson,V., Brunner,N., Holst-Hansen,C., Skobe,M., Fusenig,N.E., Carmeliet,P., Collen,D., Foidart,J.M.
Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat. Med., 1998, 4, 923-928.
I.F. = 28.114.
Van Beirs Prize, Fonds Léon Fredericq, Liege, Belgium, 2002.
Lions Club Prize, University of Liege, Liege, Belgium, 2002
Adolphe Wetrems Prize, by the Royal Academy of Science, Literature and Art of Belgium, Brussels, Belgium, 2001.
Alvarenga de Piauhy Prize by the Royal Academy of Medicine of Belgium, Brussels, Belgium. 2001.
Best Poster Prize by the American Association for Cancer Research (Travel Grant Award), Nyborg, Denmark, June 14-18, 1998.
Travel Award by AACR-AstraZeneca, American Association for Cancer Research, 97th Annual Meeting, Washington DC: April 1-5, 2006.
Travel Award by The Gorgon Research Conferences, Plasminogen Activation and Extracellular Proteolysis, Ventura, CA: February 8-13, 2004.
Post-Doc Fellowship Award by Rose and Jean Hoguet Foundation, Brussels, Belgium, 2002-2003, 2003-2004.
Post-Doc Fellowship Award by the “CENTRE ANTICANCEREUX” Liège, Belgium, 2002
Post-Doc Fellowship Award by the “KANKEROLOGISCHE STICHTING ST-MICHIEL V.Z.W.” Foundation, Brussels, Belgium, 2002.
Post-Doc Fellowship Award by the Rotary International District 1630, Belgium, 2002.
Post-Doc Fellowship Award by the “Mr et Mm F. Braconnier-Lamarche”, Liege, Belgium, 2002.
Travel Fellowship Award by “Agathon De Potter Foundation”, the Royal Academy of Science, Literature and Art of Belgium, Brussels, Belgium, 2002.
Ph.D Fellowship Award by the “Fonds National de la Recherche Scientifique” (FNRS), Belgium. October 1997 – September 2001:
Ph.D Fellowship Award by the “Centre Anticancereux” Liège, Belgium. October 1996 – September 1997: